Date updated:10-31-2006
WisdomTree offers an international fund that includes consumer staples, health care and dividend paying stocks. These stocks typically weather a slowdown or recession better than others. The fund is new and yields 2.6%. Roger Nusbaum from RealMoney points out that although this fund is new, during the last U.S. recession -- from late 2001 to early 2002 -- the index underlying this fund dramatically outperformed its benchmark index, the MSCI EAFE Index.

-
GSK
Glaxosmithkline P - $40.52
- +0.15%
- $39.84
No Analysis added

-
NVS
Novartis Ag Ads - $52.80
- +0.42%
- $52.33
No Analysis added

-
SNY
Sanofi-aventis Sa - $36.70
- -0.94%
- $36.23
No Analysis added

-
AZN
Astrazeneca Plc A - $44.98
- +0.11%
- $44.28
No Analysis added

-
NSRGY.PK
Nestle Sa Reg Shr - $46.88
- -0.68%
- $46.66
No Analysis added

-
DEO
Diageo Plc Ads Ne - $66.58
- +0.21%
- $66.41
No Analysis added

-
BTI
British Amer Tob - $65.00
- +0.57%
- $64.70
No Analysis added

-
RHHBY.PK
Roche Hldg Ltd Sp - $39.43
- -0.20%
- $39.30
No Analysis added
- Top Professional Portfolios
- 1. Navellier & Associ...
- 2. Fidelity Contrafund - ...
- 3. Argus Management
- 4. WisdomTree Intl Consum...
- 5. Charlie Munger
- show all
- Top Do-It-Yourself Portfolios
- » John Shier
- » Joy
- » tsamanuli Portfolio 1
- » brueckenc Portfolio 1
- » Fundsonly Portfolio 1
- show all
- Most Viewed Portfolios
- » Warren Buffett
- » George Soros
- » T. Boone Pickens - BP Cap...
- » Carl Icahn
- » Renaissance Technologies
- show all
By Roberto Pedone Posted on Nov. 6, 2009 According to Jim Cramer, the bears are tellinginvestors six lies. On Wednesday’s “Mad Money” TV show, Cramer said if you ...
By Roberto Pedone Posted on Nov. 5, 2009 The traders on CNBC’s “Fast Money” told their viewers what they must know after Warren Buffett announced on Tuesday his l...
By Jonas Elmerraji Posted on Nov. 4, 2009 For investors who seek out short-squeeze opportunities, there’s no time as important as earnings season. Earnings are one of...
By Stockpickr Staff Posted on Nov. 4, 2009 Regardless of why a stock is in the news, it never hurts to hear what a professional investor has to say about it. The key is...
A. Type II Diabetes in obese patients is
wrecking our health care system.
Overall, more than $1 in every $10 spent
on health care in the United States goes
toward treating Diabetes. Blood glucose
test strips alone can cost about a
dollar each and if you're testing
several times a day every day, the costs
can add up pretty quickly. XOMA has the
first drug "XOMA 052" in the last 10yrs
which will significantly impact this
industry and you would no longer require
daily insulin injections or insulin at
all, for that matter. This would save
the government billions, search on that
one and you'll make a fortune. The
government cannot continue to pay these
kinds of rising diabetes costs, when
there is an alternative which is so safe
and so effective which just became
patented in Europe.
A. The only one I own : SLX,
too hard pick a winner out all of them
Analyst Downgrades for Nov. 2, 2009. Read more here. more
These are some of the stocks mentioned on TheStreet.com TV on Sept. 2. Click the URL below each stock to watch the videos. more
Analyst Upgrades for Nov. 2, 2009. Read more here. more











Comments not available